Results from the prospective randomized UroFollow trial comparing marker-guided vs. cystoscopy-based standard follow-up in patients with low/intermediate risk bladder cancer

被引：0
|
作者：
Schmitz-Drager, B. [1 ]
Bismarck, E. [2 ]
Roghmann, F. [3 ]
Von Landenberg, N. [3 ]
Noldus, J. [3 ]
Jahn, D. [4 ]
Kernig, K. [4 ]
Hakenberg, O. [4 ]
Goebell, P. J. [1 ]
Hennenlotter, J. R. [5 ]
Erne, E. [5 ]
Stenzl, A. [5 ]
Rowinski, M. [6 ]
Schiffhorst, G. [6 ]
Baranek, T. [7 ]
Benderska-Soeder, N. [2 ]
机构：
[1] Friedrich Alexander Univ, Dept Urol & Pediat Urol, Erlangen, Germany
[2] St Theresienkrankenhaus, Dept Urol 24, Nurnberg, Germany
[3] Marien Hosp Herne, Dept Urol, Herne, Germany
[4] Univ Rostock, Dept Urol, Rostock, Germany
[5] Eberhard Karls Univ Tubingen, Dept Urol, Tubingen, Germany
[6] IGES Inst, Dept Biostat, Berlin, Germany
[7] Univ Appl Sci & Arts, Dept Clin Res, Hannover, Germany
来源：
EUROPEAN UROLOGY | 2024年 / 85卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
A0361
引用
收藏
页码：S1178 / S1178
页数：1
相关论文
共 22 条
  • [1] MULTICENTRIC PROSPECTIVE RANDOMIZED TRIAL COMPARING SADI-S VS. DUODENAL SWITCH. MID TERM FOLLOW-UP RESULTS
    Ruiz De Gordejuela, A. G.
    Gebelli, J. P.
    Nora, M.
    Pernaute, A. S.
    Pereira, A. M.
    Torres Garcia, A. J.
    OBESITY SURGERY, 2018, 28 : 112 - 112
  • [2] Music from Noise-Canceling Headphones Is Beneficial against Anxiety in Male Bladder Cancer Patients Undergoing Follow-Up Cystoscopy: A Prospective Randomized Trial
    Cho, Hyun-Jin
    Chung, Ho Seok
    Hwang, Eu Chang
    Il Jung, Seung
    Kwon, Dongdeuk
    Park, Kwangsung
    Patel, Darshan P.
    Hsieh, Tung-Chin
    UROLOGIA INTERNATIONALIS, 2024, 108 (05) : 414 - 420
  • [3] A randomized controlled trial comparing post -operative intensive follow-up with standard follow-up in high risk breast cancer patients (JCOG1204: INSPIRE)
    Hojo, T.
    Masuda, N.
    Shibata, T.
    Mizutani, T.
    Shien, T.
    Kinoshita, T.
    Iwatani, T.
    Kanbayashi, C.
    Kitagawa, D.
    Tsuneizumi, M.
    Iwata, H.
    CANCER RESEARCH, 2019, 79 (04)
  • [4] Randomized trial comparing a web-mediated follow-up via patient-reported outcomes (PRO) vs. routine surveillance in lung cancer patients: Final results
    Denis, Fabrice
    Basch, Ethan M.
    Lethrosne, Claire
    Pourel, Nicolas
    Molinier, Olivier
    Pointreau, Yoann
    Domont, Julien
    Bourgeois, Hugues Pierre
    Senellart, Helene
    Bennouna, Jaafar
    Urban, Thierry
    Septans, Anne-Lise
    Balavoine, Magal
    Solal-Celigny, Philippe
    Dueck, Amylou C.
    Letellier, Christophe
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [5] A randomised trial comparing tamoxifen vs. surgery in patients over the age of 70 with operable breast cancer - Final results after 28 years of follow-up
    Gazet, J. -C.
    Sutcliffe, R.
    EJSO, 2011, 37 (09): : 754 - 757
  • [6] Overall survival in patients with lung cancer using a web-application-guided follow-up compared to standard modalities: Results of phase III randomized trial.
    Denis, Fabrice
    Lethrosne, Claire
    Pourel, Nicolas
    Molinier, Olivier
    Pointreau, Yoann
    Domont, Julien
    Bourgeois, Hugues Pierre
    Senellart, Helene
    Tremolieres, Pierre
    Lizee, Thibaut
    Bennouna, Jaafar
    Urban, Thierry
    El Kouri, Claude
    Charron, Alexandre
    Septans, Anne-Lise
    Balavoine, Magali
    Rolley, Cyrielle
    Land, Sebastien
    Solal-Celigny, Philippe
    Letellier, Christophe
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [7] Overall survival in patients with lung cancer using a web-application-guided follow-up compared to standard modalities: Results of phase III randomized trial.
    Denis, Fabrice
    Lethrosne, Claire
    Pourel, Nicolas
    Molinier, Olivier
    Pointreau, Yoann
    Domont, Julien
    Bourgeois, Hugues Pierre
    Senellart, Helene
    Tremolieres, Pierre
    Lizee, Thibaut
    Bennouna, Jaafar
    Urban, Thierry
    El Kouri, Claude
    Charron, Alexandre
    Septans, Anne-Lise
    Balavoine, Magali
    Rolley, Cyrielle
    Landry, Sebastien
    Solal-Celigny, Philippe
    Letellier, Christophe
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (18)
  • [8] Adjuvant vs. progression-triggered treatment with gemcitabine in platinum-ineligible high-risk bladder cancer patients: Long-term follow-up of a randomized phase 3 trial
    Heinzelbecker, Julia
    Spieler, Natalie
    Kuehn, Michael
    Fischer, Claus
    Volkmer, Bjoern
    von Rundstedt, Friedrich
    Albers, Peter
    Becht, Eduard
    Bannowsky, Andreas
    Weber, H. Matthias
    Hofmann, Rainer
    Mueller, Markus
    Langbein, Sigrun
    Steiner, Gabriel
    Retz, Margitta
    Karmradt, Joern
    Wagenpfeil, Gudrun
    Wellek, Stefan
    Lehmann, Jan
    Stoeckle, Michael
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (08) : 356e19 - 356e30
  • [9] Long-term follow-up of a randomized prospective trial comparing a standard 81 mg dose of intravesical bacille Calmette-Guerin with a reduced dose of 27 mg in superficial bladder cancer
    Martínez-Piñeiro, JA
    Flores, N
    Isorna, S
    Solsona, E
    Sebastián, JL
    Pertusa, C
    Rioja, LA
    Martínez-Piñeiro, L
    Vela, R
    Camacho, JE
    Nogueira, JL
    Pereira, I
    Resel, L
    Muntañola, P
    Galvis, F
    Chesa, N
    De Torres, JA
    Carballido, J
    Bernuy, C
    Arribas, S
    Madero, R
    BJU INTERNATIONAL, 2002, 89 (07) : 671 - 680
  • [10] Prolonged follow-up of HBV liver transplanted patients: Results from a randomized study comparing lamivudine vs. lamivudine plus HBIg in the prevention of HBV recurrence after liver transplantation
    Buti, M
    Mas, A
    Prieto, M
    Casafont, F
    Gonzalez, A
    Miras, M
    Valdes, A
    Herrero, J
    JOURNAL OF HEPATOLOGY, 2003, 38 : 37 - 37
123